Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Urinary Bladder Neoplasms × BCG Vaccine × Clear all

Phase

Phase 3 12 Phase 2 7 Phase 1/2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Side Effect of Drug 1 Oligospermia 1 Non-Muscle Invasive Bladder Neoplasms 1 Fibrosis 1

Interventions

Rocuronium 2 Ofloxacin 2 Mitomycin 2 5-aminolevulinic acid hexyl ester 2 remimazolam 1 penpulimab 1 pembrolizumab 1 mebeverine 1 lornoxicam 1 enfortumab vedotin 1 disitamab vedotin 1 Ultrasonography 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Tobacco Use Cessation Devices 1 Tamsulosin 1 Sugammadex 1 Specimen Handling 1 Psychiatric Rehabilitation 1 Propofol 1 Polymerase Chain Reaction 1 Nitrofurantoin 1 Neuromuscular Blockade 1 Neuroleptanalgesia 1 Nephroureterectomy 1 Neostigmine 1 Midazolam 1 Metformin 1 Mepivacaine 1 Magnetic Resonance Spectroscopy 1 Levofloxacin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03790384 2018-12-31

MITOBCG

Azienda Ospedaliera "Sant'Andrea"

Phase 4 Unknown

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡